Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|5|629-637

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.5, 2006-05, pp. : 629-637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agonists and Antagonists of Protease Activated Receptors (PARs)

By  

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 243-265

Bentham Science Publishers

Access to resources Recommend Favorite

Pro-inflammatory mechanisms of a non-steroidal anti-inflammatory drug

By Wood I.C.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 3, 2002-03 ,pp. : 109-109

Elsevier

Access to resources Recommend Favorite

Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis

By Hyun Eric   Andrade-Gordon Patricia   Steinhoff Martin   Beck Paul   Vergnolle Nathalie  

Inflammation Research, Vol. 59, Iss. 9, 2010-09 ,pp. : 699-709

Springer Publishing Company

Access to resources Recommend Favorite

PAR2 antagonists: anti-inflammatory agents?

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Proteases and Protease-Activated Receptors (PARs): Novel Signals for Pain

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 6, 2005-06 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite